These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

701 related articles for article (PubMed ID: 22369456)

  • 1. A retrospective study of AIDS-associated cryptomeningitis.
    Sachdeva RK; Randev S; Sharma A; Wanchu A; Chakrabarti A; Singh S; Varma S
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1220-6. PubMed ID: 22369456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
    van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
    N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival time of HIV-infected patients with cryptococcal meningitis.
    Chottanapund S; Singhasivanon P; Kaewkungwal J; Chamroonswasdi K; Manosuthi W
    J Med Assoc Thai; 2007 Oct; 90(10):2104-11. PubMed ID: 18041430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptococcal meningitis in HIV infected: experience from a North Indian tertiary center.
    Kumar S; Wanchu A; Chakrabarti A; Sharma A; Bambery P; Singh S
    Neurol India; 2008; 56(4):444-9. PubMed ID: 19127040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic markers in AIDS-related cryptococcal meningitis.
    Majumder S; Mandal SK; Bandyopadhyay D
    J Assoc Physicians India; 2011 Mar; 59():152-4. PubMed ID: 21751623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
    Powderly WG; Saag MS; Cloud GA; Robinson P; Meyer RD; Jacobson JM; Graybill JR; Sugar AM; McAuliffe VJ; Follansbee SE
    N Engl J Med; 1992 Mar; 326(12):793-8. PubMed ID: 1538722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptococcal meningitis in HIV-infected patients: a longitudinal study in Cambodia.
    Espié E; Pinoges L; Balkan S; Chanchhaya N; Molfino L; Narom P; Pujades-Rodríguez M
    Trop Med Int Health; 2010 Nov; 15(11):1375-81. PubMed ID: 20868415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.
    Mussini C; Pezzotti P; Miró JM; Martinez E; de Quiros JC; Cinque P; Borghi V; Bedini A; Domingo P; Cahn P; Bossi P; de Luca A; d'Arminio Monforte A; Nelson M; Nwokolo N; Helou S; Negroni R; Jacchetti G; Antinori S; Lazzarin A; Cossarizza A; Esposito R; Antinori A; Aberg JA;
    Clin Infect Dis; 2004 Feb; 38(4):565-71. PubMed ID: 14765351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of cryptococcal meningitis in HIV-infected patients following immune reconstitution.
    Seddon J; Mangeya N; Miller RF; Corbett EL; Ferrand RA
    Int J STD AIDS; 2009 Apr; 20(4):274-5. PubMed ID: 19304977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature.
    Skiest DJ; Hester LJ; Hardy RD
    J Infect; 2005 Dec; 51(5):e289-97. PubMed ID: 16321643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
    J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole.
    Schaars CF; Meintjes GA; Morroni C; Post FA; Maartens G
    BMC Infect Dis; 2006 Jul; 6():118. PubMed ID: 16846523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B.
    Pitisuttithum P; Tansuphasawadikul S; Simpson AJ; Howe PA; White NJ
    J Infect; 2001 Nov; 43(4):226-33. PubMed ID: 11869059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis.
    Liao CH; Chi CY; Wang YJ; Tseng SW; Chou CH; Ho CM; Lin PC; Ho MW; Wang JH
    J Microbiol Immunol Infect; 2012 Aug; 45(4):296-304. PubMed ID: 22608531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients].
    Metta HA; Corti ME; Negroni R; Helou S; Arechavala A; Soto I; Villafañe MF; Muzzio E; Castello T; Esquivel P; Trione N
    Rev Argent Microbiol; 2002; 34(3):117-23. PubMed ID: 12415893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MORTALITY AFTER CLINICAL MANAGEMENT OF AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS IN KENYA.
    Baldassarre R; Mdodo R; Omonge E; Jaoko W; Baddley J; Pappas P; Aban I; Odera S; Suleh A; Jolly PE
    East Afr Med J; 2014 May; 91(5):145-51. PubMed ID: 25684784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up and survival of antiretroviral-naive patients with cryptococcal meningitis in the pre-antiretroviral therapy era, Gauteng Province, South Africa.
    Park BJ; Shetty S; Ahlquist A; Greenbaum A; Miller JL; Motsi A; McCarthy K; Govender N;
    Int J STD AIDS; 2011 Apr; 22(4):199-203. PubMed ID: 21515751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptococcal meningitis in patients with the acquired immunodeficiency syndrome.
    Zeind CS; Cleveland KO; Menon M; Brown JR; Solomon DK
    Pharmacotherapy; 1996; 16(4):547-61. PubMed ID: 8840361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
    J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
    Saag MS; Powderly WG; Cloud GA; Robinson P; Grieco MH; Sharkey PK; Thompson SE; Sugar AM; Tuazon CU; Fisher JF
    N Engl J Med; 1992 Jan; 326(2):83-9. PubMed ID: 1727236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.